•
Dec 31, 2019

Voyager Therapeutics Q4 2019 Earnings Report

Total Revenue
$32.7M
Previous year: $2.01M
+1527.2%
EPS
-$0.34
Previous year: -$0.7
-51.4%
Gross Profit
-$3.88M
Previous year: -$14.9M
-74.0%
Cash and Equivalents
$86M
Previous year: $46.9M
+83.6%
Free Cash Flow
-$26.7M
Previous year: -$24.9M
+7.5%
Total Assets
$355M
Previous year: $177M
+100.4%

Voyager Therapeutics

Voyager Therapeutics